International Patent: ANTI-AMHR2 ANTIBODIES AND USES FOR THE PREVENTION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME

GENEVA, Aug. 31 -- INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE filed a patent application (EP2026/054312) for “ANTI-AMHR2 ANTIBODIES AND USES FOR THE PREVENTION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME”. With publication no. WO/2026/175864, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....